|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||137.02 - 143.25|
|52 Week Range||117.08 - 464.00|
|Beta (5Y Monthly)||-0.29|
|PE Ratio (TTM)||2.79|
|Earnings Date||Aug 08, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 02, 2022|
|1y Target Est||252.86|
Subscribe to Yahoo Finance Plus to view Fair Value for BNTX
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's vote to update its COVID-19 boosters.
Under the deal, the U.S. government will get 105 million doses and have the option to purchase more. The doses would be for a fall booster drive.
Pfizer Inc. and BioNTech SE said late Wednesday they have inked a new agreement with the U.S. government to supply 105 million doses of their COVID-19 vaccines, including a formulation adapted to target omicron variants, pending approval from the FDA. The two pharma companies said the doses are expected to be delivered as soon as late summer, and continue into the end of the year. Under the agreement, the U.S. has the option to buy up to 195 million additional doses, which would bring the total